In fact, in patients with advanced ovarian cancer, we have demonstrated a correlation between high levels of IL-6 and the inability of lymphocytes to produce adequate level of IL-2 or express IL-2 receptor at physiological levels [24]. This evidence concerns the gene IL6 and ovarian carcinoma.